News

November 22, 2024
PRNewswire
Artificial Intelligence

Delta Attended COP29 for the 17th Consecutive Time, Focusing on AI Datacenter Energy Efficiency and Net-Zero Buildings

Delta marked its 17th consecutive participation in the 29th United Nations Climate Change Conference (UNFCCC COP29) held in Baku, Azerbaijan. This year, Delta co-hosted a side event on 21st with the American...

November 22, 2024
PRNewswire
Networking

Meet the 8849 TANK Pad: The World’s First 5G Rugged Projector Tablet

Today, we are excited to announce our latest invention – 8849 Tank Pad, the world’s first 5G rugged projector tablet. It’s built to withstand extreme environments, ensuring uncompromising performance...

November 22, 2024
PRNewswire
Healthcare

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S....

November 22, 2024
PRNewswire
Biotechnology

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for...

November 22, 2024
PRNewswire
Press Release

China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

China has entered a transformative phase in its economic evolution, prioritizing sustainability and innovation over rapid growth. This strategic shift, known as high-quality development, represents a fundamental change aimed...

November 21, 2024
PRNewswire
Biotechnology

Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans

Vicebio Ltd (“Vicebio”), a biopharmaceutical company pioneering next-generation vaccines for life-threatening respiratory viruses, today announces its progress in the ongoing VXB-241 bivalent RSV-hMPV Phase 1 (P1) study as well as...

November 21, 2024
PRNewswire
Networking

Neutral host networks 38% greener and more cost-effective than standalone 5G networks, research reveals

New research revealed that Neutral Host Networks (NHNs) are 38% greener and up to 47% more cost-effective than traditional standalone 5G deployments. Neutral Host Networks: A Solution to Greener and...

November 21, 2024
Business Wire
Artificial Intelligence

IEEE Standards Association Announces Joint Specification V1.0 for the Assessment of the Trustworthiness of AI Systems

In a major step forward for artificial intelligence governance, the IEEE Standards Association (IEEE SA), the global, consensus-building standards development organization (SDO) of IEEE, the world’s largest technical professional organization dedicated...

November 21, 2024
PRNewswire
Healthcare

BioWorld by Clarivate Highlights Gaps in Women’s Health Research and Investment in New Special Series

BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, ‘Healing the Health Divide.‘ This seven-part series sheds light on the persistent disparities in women’s...

November 21, 2024
Business Wire
Biotechnology

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)

Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO® (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated...